AMC vs IMAX: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. AMC and IMAX share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined AMC and IMAX exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

AMC Entertainment Holdings, Inc. (NYSE: AMC), headquartered in Leawood, Kansas, is the largest movie-theater exhibitor in the United States and the world, operating theatres across the U.S. and Europe under the AMC, Odeon, and other banners. The company makes money primarily from box-office admissions and from high-margin food and beverage sales, supplemented by on-screen advertising and premium formats. Its results are tightly tied to the strength of the theatrical film slate: a strong year of major releases lifts attendance and revenue, while a thin or delayed slate (as during the pandemic and the 2023 Hollywood strikes) can sharply reduce both. Full-year 2025 revenue was approximately $2.25 billion on attendance of roughly 104.7 million guests, and Q1 2026 revenue grew approximately 21% year over year to about $1.05 billion as the recovery continued.

Full AMC guide

IMAX Corporation designs and markets premium large-format cinema systems and licenses proprietary technology that lets studios remaster films into the IMAX format. Rather than owning most theaters itself, IMAX runs an asset-light model: it sells or leases its projection and sound systems to exhibitor partners, then earns ongoing revenue tied to ticket sales through revenue-share and joint-venture arrangements. Its two reporting segments are Technology Products and Services (the systems, maintenance, and network operations) and Content Solutions (film remastering, distribution, and the growing slate of local-language titles). By 2025 the IMAX network spanned more than 1,700 theaters globally, larger than rival premium formats.

Full IMAX guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• AMC drivers: Box-Office Recovery and Film Slate; Premium Formats and Concessions.
• IMAX drivers: Record box office and premium share; Local-language content expansion.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The dominant risk is the balance sheet: AMC carried roughly $4 billion in corporate borrowings (and a larger total-debt figure including leases) against a few hundred million dollars of cash and a stockholders' deficit as of early 2026, so interest costs and refinancing needs weigh heavily on the equity. For IMAX, iMAX's results depend heavily on the theatrical film release calendar, which it does not control, so a weak slate of major titles in any period can pressure box office and revenue.

Pick AMC if you believe its drivers more; IMAX if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the AMC and IMAX guides.

AMC. AMC's valuation is unusual because the equity story is driven heavily by debt and dilution rather than by a simple multiple of earnings. The company is not consistently profitable on a net-income basis (it reported net losses in 2025 and Q1 2026), so traditional price-to-earnings metrics are not meaningful; instead, the relevant lens is enterprise value relative to a recovering but still-negative free cash flow, against roughly $4 billion of corporate borrowings and a stockholders' deficit. Because shares outstanding have grown into the hundreds of millions, the market capitalization is spread across far more shares than a few years ago, so any operating improvement must be weighed against ongoing dilution. The stock's price has also historically reflected retail sentiment and short interest tied to its meme-stock status, which can decouple it from fundamentals in both directions.

IMAX. As of February 2026, IMAX reported best-ever full-year 2025 revenue of about $410 million with a net income margin near 11%, and the stock traded around the high $30s for a market cap near $2.2 billion. The trailing price-to-earnings multiple of roughly 60x is high relative to the broader market, reflecting expectations for continued record box office and network growth. The 2026 guidance of about $1.4 billion in global box office and 160 to 175 installations frames the growth the valuation assumes.

Headline figures (approximate, 2026-06-27): AMC shows revenue (fy2025) ~$2.25 billion (up ~14% YoY), revenue (q1 2026) ~$1.05 billion (up ~21% YoY), attendance (fy2025) ~104.7 million guests (up ~8% YoY), net loss (q1 2026) ~$117 million (narrowed from ~$202 million); IMAX shows revenue (fy2025) ~$410 million (+16%), net income margin ~11%, adjusted ebitda margin ~45% (record), global imax box office (2025) ~$1.28 billion (record).

AMC and IMAX are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined AMC and IMAX exposure against your real portfolio. It is not an investment adviser.